Urine is a toxic waste product from the body that needs to be collected and disposed of in a controlled fashion.
It is also collected to monitor health and diagnose disease.
TillaCare is now bringing to market a cutting-edge urine collection and management system that aims to improve quality of life and reduce health risks for incontinent adults as well as help sampling urine for test purposes.
A revolution in urine management. UriCap Female is a non-invasive, external urine collection device designed to fit the female anatomy around the urethra. It connects to a standard urine drainage bag. UriCap helps prevent contact between urine and the skin, a common reason for skin irritation. UriCap is particularly useful for patients at night or that are bedridden and suffer from urinary incontinence.
The device offers an innovative solution for patients in nursing homes, homecare or hospitals. UriCap is the only external alternative to an internal catheter for monitoring urine, a common problem among elderly. UriCap Female is patent pending and registered as an FDA 510k exempt medical device.
“The device is a significant innovation in geriatric medicine and will contribute greatly to improving the quality of life of patients suffering from urinary incontinence and minimizing the serious consequences of this condition. The device has several advantages for patients as well as for the medical team. The same is true for treatment in hospitals when the device is used as a replacement for a catheter.”
”UriCap Female is a unique solution for women and the only fixed external urine collection device that totally avoids the odor of urine, keeping the patient dry and thus avoiding the toxic effect of urine on the skin. At the same time, it enables the monitoring of dehydration status because UriCap Female allows you to observe the volume and the color of the urine.”
Dr Michael Cohn, MD.
3 nursing homes in Israel (2017)
756 tests performed
30 female patients
100% performance (leakage-free & functioning)
Zero adverse events
The following abstract was published in a poster that was approved and presented
by Dr Daniel Altman at the Swedish Association for Obstetrics and Gynecology Conference.
August 27-29, 2018 in Uppsala Sweden.
“The device met all expectations; no leaks were observed during the hours of use and during the whole night.
In addition, the device was convenient, easy to install and when used long-term also resulted in an improvement of the patient’s skin condition.”
”The installation was easy, I did not feel any pain. It was comfortable during the whole night and I had no leaks. I could sleep all night long.”
”The device was comfortable and I slept all night long, I could move freely and it was not leaking.”
”The device was good because they could monitor my urine”
”Since I’m working a lot of nights, I got a very good impression from the UriCap Female:
The patient kept dry all night and slept better than usual.”
TillaCare (previously known as GR Dome Medical) was established by experts in medicine and technology in Israel and Sweden who were disappointed with the lack of innovation and effective solutions for urine collection in chronic urine incontinence.
TillaCare’s mission is to bring to market cutting edge urine collection for incontinent men & women that dramatically reduces health risks, costs, and increases comfort as well as preventing social isolation.
Today’s solutions for women are either an invasive catheter or an external diaper. Both have major disadvantages. For men there is an alternative with the external condom catheter. There are no widely adopted options for women.
The team at TillaCare has after four years of experimenting managed to design the first easy to use external and leak-free urine collection device for women that will revolutionize the care of elderly and incontinent women.
UriCap Female role in fighting Covid-19
In any healthcare or homecare setting, the UriCap Female decreases the number of necessary care interactions related to frequent diaper changes. Accordingly, UriCap Female can be recommended to be part of a strategy to prevent transmission of the Covid-19 virus for elderly female patients and staff alike.
Read more here
Eloquest Healthcare and TillaCare form new partnership for UriCap Female distribution in U.S. acute care hospitals .
Read press release here
Reducing the risk of Indwelling Catheter – Associated UTI in female patients by implementing an alternative female external urinary collection device
Read article here